Minute Insight: Novartis, Medtronic, NHS Trust And RYSE Join Forces To Spur Development Of Digital Heart Health Solutions
Executive Summary
Novartis Biome UK Heart Health Catalyst is taking applications from start-ups, researchers and technologists through 31 August. As much as £3m is up for grabs and specific interest in non-invasive lipid measurement techniques and at-home blood pressure testing using software as a medical device.
You may also be interested in...
Notified Body Process For Consulting EMA On Companion Diagnostics
A new EU guideline outlines the steps that notified bodies can take to facilitate the European Medicines Agency’s assessment of the appropriateness of a companion diagnostic’s use with a drug.
FDA Approves Companion Diagnostic For Obesity Drug
The US FDA has given thumbs-up to a genetic test from PreventionGenetics, the first agency-approved class II molecular companion diagnostic that looks for genetic deficiencies associated with obesity.
FoundationOne Nabs US FDA Approval As Companion Diagnostic For Rare Cancers
The approval is the 25th indication for the diagnostic, but the first for any companion diagnostic to Roche’s Rozlytrek.